• Profile
Close

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States

Liver International Mar 01, 2019

Shaheen AA, et al. - In patients with cirrhosis, researchers evaluated readmission rates and hospitalization costs and identified risk factors for 90-day readmission. They conducted a weighted analysis of the 2014 Nationwide Readmission Database to identify US adults with cirrhosis-related complications and to evaluate readmission rates at 30, 60, and 90 days post-index hospitalization. The data presented in this work showed a quarter of patients admitted to cirrhosis-related complications were readmitted within 90 days, which represents a significant economic burden associated with the readmission of this population. Interventions and allocation of resources to reduce the rate of readmission of cirrhotic patients remain critical. The index admission estimate for the weighted cumulative national cost was $1.8 billion vs $0.5 billion for readmission. Ascites, hepatic encephalopathy, and bleeding esophageal varices were the main causes of readmission. Male sex, age < 60 years, having private insurance, having ≥ 3 comorbid conditions, and being discharged against medical advice were independent predictors of 90-day readmissions.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay